Cytokinetics (CYTK) Receivables - Net: 2016-2025
Historic Receivables - Net for Cytokinetics (CYTK) over the last 8 years, with Sep 2025 value amounting to $1.8 million.
- Cytokinetics' Receivables - Net rose 640.98% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 640.98%. This contributed to the annual value of $16.6 million for FY2024, which is 1197.74% up from last year.
- Cytokinetics' Receivables - Net amounted to $1.8 million in Q3 2025, which was down 78.50% from $8.4 million recorded in Q2 2025.
- Cytokinetics' Receivables - Net's 5-year high stood at $51.8 million during Q4 2021, with a 5-year trough of $147,000 in Q4 2022.
- Its 3-year average for Receivables - Net is $3.6 million, with a median of $1.5 million in 2023.
- In the last 5 years, Cytokinetics' Receivables - Net tumbled by 99.72% in 2022 and then soared by 1,197.74% in 2024.
- Cytokinetics' Receivables - Net (Quarterly) stood at $51.8 million in 2021, then plummeted by 99.72% to $147,000 in 2022, then soared by 772.79% to $1.3 million in 2023, then spiked by 1,197.74% to $16.6 million in 2024, then surged by 640.98% to $1.8 million in 2025.
- Its Receivables - Net stands at $1.8 million for Q3 2025, versus $8.4 million for Q2 2025 and $2.0 million for Q1 2025.